Navigation Links
Gen-Probe to Webcast Presentation at the 30th Annual J.P. Morgan Healthcare Conference
Date:1/4/2012

SAN DIEGO, Jan. 4, 2012 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company will present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2012 at approximately 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time).  The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at www.gen-probe.com. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and are forward-looking statements.  Forward-looking statements are not guarantees of performance.  They involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied.  For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including our most recent Form 10-K, and all subsequent periodic filings.  We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro
Investor Relations
858-410-8904

 


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Gen-Probe to Webcast Presentation at the Oppenheimer 22nd Annual Healthcare Conference
2. Gen-Probe Announces Webcast of Second Quarter 2011 Earnings Conference Call
3. Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference
4. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
5. Gen-Probe Reports Financial Results for the First Quarter of 2011
6. Gen-Probe to Webcast Three Upcoming Investor Presentations
7. Gen-Probe Announces $150 Million Stock Repurchase Plan
8. Gen-Probe to Webcast Two Upcoming Investor Presentations
9. Gen-Probe Announces Webcast of Third Quarter 2010 Earnings Conference Call
10. Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
11. Patrick J. Sullivan Elected to Gen-Probe Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Market Size & Forecast By Type (Insource IONM, Outsource IONM), ... report to their offering. ... The global Intraoperative Neuromonitoring (IONM) market ... intraoperative neuromonitoring market is anticipated to witness significant growth in ...
(Date:3/29/2017)... , March 29, 2017  Bodycad announced today ... Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental ... truly personalized orthopaedic restoration. Bodycad is the first ... joint reconstruction implant system. Bodycad,s ... personalized restoration of the patient,s unique anatomical features ...
(Date:3/29/2017)... , March 29, 2017 Wound care ... promote healing of the wound. The industry mainly consists ... products for the treatment of wounds caused by mechanical, ... due to diseases such as diabetes, skin related diseases, ... Europe was the largest region in ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... During the last week of March, Chad Kawa, MD of Revere Health ... local community. , Colon cancer is the second leading cause of cancer deaths ... is small, confined and easier to treat. If you are 50 or older, colonoscopies ...
(Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced ... dealer websites for its network of more than 650 U.S.-based dealers. Rhino, a member ... including rotary and flail mowers and cutters, rear blades, post hole diggers, pasture renovators, ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... professional squash, announced it has enlisted New York City-based sports and entertainment marketing ... develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes ...
(Date:3/29/2017)... ... ... Full Contact K9, an Atlanta-based dog services provider, has recently teamed up ... owners in creating legally-enforceable pet trusts for their canine companions. , Therilus, a ... their new companion. Says Evan Dunbar, CEO of Full Contact K9, “When our clients ...
Breaking Medicine News(10 mins):